Rheumatology Training Day: Metabolic bone and paraneoplastic manifestations May 24th 2018, BRS SpR organiser: Dr. S Hadavi and Dr. G Brown 9:30 10:00 Registration & coffee – 10:00 10:45 tips for the Osteoporosis clinic” – “Practical Roberto Cayado-Lopez Specialist Osteoporosis Nurse, Addenbrooke’s Hospital 10:45 11:30 and immunotherapy-associated arthritis – “Paraneoplastic “ Dr Anshuman Malaviya Consultant Rheumatologist, Addenbrooke’s Hospital 11:30 11:45 Coffee – 11:45 12:30 Cases in Osteoporosis and future treatments” – “Clinical Dr Mohammad Nisar Consultant Rheumatologist, Luton and Dunstable Hospital 12:30 13:30 Lunch – 13:30 14:15 use and abuse” – “DXA – Dr Gavin Clunie Consultant Rheumatologist, Addenbrooke’s Hospital 14:15 15:00 bone diseases” – “Rare Dr Kenneth Poole Consultant Rheumatologist, Addenbrooke’s Hospital 15:00 15.30 SpR Forum – Celegene Ltd, Pfzier, Abbvie, Lilly, Roche and Bristol-Myers Squibb have provided funding for this event, however have not influenced the agenda or selection of speakers in any way.
Rheumatology Training Day: Metabolic bone and paraneoplastic manifestations May 24th 2018, BRS SpR organiser: Dr. S Hadavi and Dr. G Brown 9:30 – 10:00 Registration & coffee 10:00 – 10:45 “Practical tips for the Osteoporosis clinic” Roberto Cayado-Lopez Specialist Osteoporosis Nurse, Addenbrooke’s Hospital 10:45 – 11:30 “Paraneoplastic and immunotherapy-associated arthritis “ Dr Anshuman Malaviya Consultant Rheumatologist, Addenbrooke’s Hospital 11:30 – 11:45 Coffee 11:45 – 12:30 “Clinical Cases in Osteoporosis and future treatments” Dr Mohammad Nisar Consultant Rheumatologist, Luton and Dunstable Hospital 12:30 – 13:30 Lunch 13:30 – 14:15 “DXA – use and abuse” Dr Gavin Clunie Consultant Rheumatologist, Addenbrooke’s Hospital 14:15 – 15:00 “Rare bone diseases” Dr Kenneth Poole Consultant Rheumatologist, Addenbrooke’s Hospital 15:00 – 15.30 SpR Forum Celegene Ltd, Pfzier, Abbvie, Lilly, Roche and Bristol-Myers Squibb have provided funding for this event, however have not influenced the agenda or selection of speakers in any way.
rheumatologytd05.18.docx